摘要:
The invention provides compounds and methods of their use in the detection of apoptosis and necrosis. The compounds and methods are based on conjugates formed with a dehydrogenase such as lactate dehydrogenase, alcohol dehydrogenase, aldehyde dehydrogenase, and malate dehydrogenase. The compounds and methods are useful in the diagnosis of conditions characterized by apoptosis, including cancer, cardiac disease, neurologic disease including stroke, and autoimmunity.
摘要:
본 발명은 알츠하이머병 또는 경도 인지 장애 진단 방법에 관한 것이다. 본 발명의 알츠하이머병 또는 경도 인지 장애 진단 방법은 후각 조직의 miR-206의 발현 수준을 확인하여, 알츠하이머병 및 경도 인지 장애 진단에 높은 진단율을 보이며, 적은 비용으로 진단이 가능하며, 조직 검사의 안정성이 매우 높아 알츠하이머병 또는 경도 인지 장애 진단에 현저한 효과를 보인다.
摘要:
본 발명은 (a) Beclin1 단백질을 포함하는 세포에 분석하고자 하는 시험 물질을 접촉시키는 단계; 및 (b) 상기 Beclin1 단백질의 30번째 세린(serine) 아미노산 잔기의 인산화(phosphorylation) 정도를 분석하는 단계를 포함하는 자가포식(autophagy) 활성제 또는 억제제를 스크리닝하는 방법을 제공한다. 상기 Beclin1 단백질의 인산화가 상향-조절(up-regulation)되는 경우에, 상기 시험물질은 자가포식 활성제(activator)로 판정하고, 상기 Beclin1 단백질의 인산화가 하향-조절(down-regulation)되는 경우에, 상기 시험물질은 자가포식 억제제(inhibitor)로 판정한다. 본 발명은 ULK1이 Beclin1의 30번째 세린 아미노산 잔기가 인산화하는 기작을 최초로 규명한다.
摘要:
A panel for monitoring levels of biomarkers in ruminants, including an assay having at least one inflammation monitoring test, at least one oxidative stress monitoring test, and at least one antioxidant activity monitoring test. A method of monitoring the health of ruminants, by collecting a sample from the ruminant, applying the sample to an assay panel, performing at least one inflammation monitoring test, at least one oxidative stress monitoring test, and at least one antioxidant activity monitoring test in the panel, and determining levels of biomarkers related to inflammation, oxidative stress, and antioxidant activity and therefore providing information regarding the ruminant's relative health and/or risk of developing one or more diseases.
摘要:
The present invention pertains to the recognition that a specific oxMIF form of MIF is useful as a diagnostic marker in (MIF-related) diseases, in particular for example monitoring of disease progression. The present invention also pertains to the respective use of a diagnostic kit and a respective diagnostic assay and pertains to advantageous respective antibodies.
摘要:
Abstract The present invention discloses peptide biomarkers of physical activity derived from endorepellin, such as the LG3 peptide of endorepellin and fragments thereof. In particular, the invention discloses reagents and methods of detecting, monitoring, determining or assessing physical activity level, health, fitness and or tissue breakdown based on using an endorepellin peptide biomarker.
摘要:
A method for validating quantification of biomarkers, the biomarkers being quantified using a quantification technique of a selected type, and the method including determining a plurality of biomarker values, each biomarker value being indicative of a value measured or derived from a measured value, for at least one corresponding biomarker of the biological subject and being at least partially indicative of a concentration of the biomarker in a sample taken from the subject, determining at least one control value by determining a combination of biomarker values, comparing each control value to a respective control reference and determining if the biomarker values are valid using results of the comparison.
摘要:
The present invention relates generally to the field of nutrition and health, particular, the present invention relates to alpha-keto-isovalerate as a biomarker urine of the efficacy of prebiotics for the prevention of diet induced weight gain.
摘要:
The present invention relates generally to the field of nutrition and health. In particular, the present invention relates to indoxyl sulfate as a biomarker in urine of the efficacy of prebiotics for the prevention of diet induced weight gain.